The report covers a study of the global protein supplement market and provides the detailed analysis of the market trends, future estimations, and a thorough study of the global market based on type, form, source, distribution channel, and region. By type, the market is segmented into casein, whey protein, egg protein, soy protein, and others. Based on form, the market is segmented into powder, RTD liquid and protein bars. On the basis of source, it is segmented into animal and plant. Based on distribution channel, the market is segmented into supermarkets/hypermarkets, online, chemist/drugstore, nutrition store, health food store, specialist sports store, and others. Based on region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, KSA, South Africa and Rest of LAMEA). The study highlights Porter’s five forces analysis to determine the factors affecting the market growth. These factors include raw material prices, intense competition, end users, manufacturers, and suppliers. To understand the market movement, drivers, restraints, and opportunities are explained in the report.

The revenues generated through the sale of proteomics instruments, reagents, and services are considered in the scope of the current report. However, revenues associated with related technologies such as transcriptomics and genomics are not considered in the report.

Pharmacogenomics falls in the branch of precision medicine and deals with the drug response in an individual based on his/her genetic profile. It hence allows doctors to devise a tailor-made prescription for patients suffering from life-threatening diseases such as cancer, neurological, and cardiovascular disorders. Furthermore, use of pharmacogenomics-based diagnostic tests facilitates improved drug response, reduced probability of drug failure, enhanced drug efficiency, and higher survival rate in case of cancer. Pharmacogenomics majorly includes the use of bioinformatics tools and several molecular biology techniques to determine the reason for an individual patient's illness at a molecular level. Furthermore, treatment is followed with the use of required dosage to address an individual patient's illness. This report takes into consideration the revenue generated by the sales of instruments, reagents, software, solutions, services, and therapeutics used to practice pharmacogenomics.

Orthobiologics are substances that orthopedic surgeons use to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in the body; and when used in higher concentrations, orthobiologic substances help speed up the healing process. Osteoarthritis (OA) of knee is a common global cause of disability. There is an increase in the number of non-operative treatment options. Orthobiologic therapy has emerged as a novel yet effective modality for early OA. The report covers profiles of key product manufacturers in the market. These include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc.

Europe region holds the largest market share in the plant genotyping equipment market owing to the increasing number of initiatives taken by the European Union (EU). The ever-rising demand for food and the need for genetically modified high-quality crops along with the presence of major plant biotech solution providers are expected to boost the demand for plant genotyping equipment in the European region. Europe has always been the dominant force in the food and agriculture industry with presence of top agricultural exporting countries such as Germany, Netherlands, and France.

Currently, the capacity to synthesize DNA is much lower than the ability to sequence it. However, technological advances and efforts to improve efficiency of DNA synthesis are expected to bridge the difference. For instance, in June 2018, the Joint BioEnergy Institute based at the Lawrence Berkeley National Laboratory introduced a novel approach for accurate, faster, and cheaper synthesis of sequences using polymerase-nucleotide conjugates. Post completion of Human Genome Project, a number of organisms have been screened and sequenced under various studies. Data generated through these sequencing experiments is employed for various applications.

The genotyping market is segmented on the basis of product, technology, applications, and region. Based on product, the market is categorized into instruments, reagents & kits and services. Reagents accounted for the largest market share owing to its wide applications in cellular manipulation, DNA sequencing and PCR cleanup. On the basis of technology, the market is further segmented into PCR, capillary electrophoresis, mass spectrometry, sequencing, microarray and others. Sequencing is estimated to be the fastest growing technology segment due to various developments in its technology. Based on application, the market is segmented into diagnostics, drug discovery & development, personalized medicines,

Rising focus on glycomics and proteomics research has led to high growth of glycomics market. Huge investments in this field have also enabled academic researchers to develop new tools. Thus, the field of glycoscience is growing, which is a high-impact rendering driver for the market. As per many researchers, glycans are essential in biological processes; research on them helps researchers in understanding the biology more comprehensively, without specializing in glycobiology. This provides with a wide set of potential applications for glycan analysis. An example of such research is the interlaboratory study, conducted from June 2015 to February 2016, by The National Institute of Standards and Technology. This study was conducted in 76 laboratories and was aimed at measuring glycosylation in monoclonal antibodies. According to NCBI, another research study was conducted by the National Institute of General Medical Sciences (NIGMS) through a grant supported Consortium for Functional Glycomics (CFG). This research has helped more than 500 researchers focus on issues related to glycomics. It aimed at studying the importance of carbohydrate-protein interactions at the cell surface in cell-cell communication. It helped in developing custom-made DNA microarrays that characterize glycan binding proteins and glycosyltransferases.